Category Archives: AIDS2016

International AIDS Conference, Durban, South Africa

AIDS 2016: Plenary talk proposes $90, $90, $90 as cost of HIV and viral hepatitis drugs

By on .

DURBAN, South Africa – Today’s plenary session today saw a new 90-90-90 goal set in a talk on tuberculosis and viral hepatitis today: $90 for HIV treatment, $90 for hepatitis B treatment and $90 for hepatitis C cure. Dr.Anton Pozniak, the director of HIV services at Chelsea and Westminster Hospital NHS Trust in London, issued the challenge. The hepatitis […]

AIDS 2016: Fund decline, incidence rise present clear, current threats to HIV services, research, “ending AIDS,” response watchers say

By on .

DURBAN, South Africa – Global funding for HIV responses has declined in real numbers and in impact potential for the first time in five years, researchers and advocates told reporters here Tuesday, injecting reality into an ambition focused conference. The 13 percent drop in international donor funding from 2014 to 2015 means less money to support effective responses […]

AIDS 2016: Opening talks celebrate early pivotal action, and those who carry on

By on .

“AIDS exposes us in all our human vulnerabilities . . .” Justice Edwin Cameron, July 19, 2016 DURBAN, South Africa – Justice Edwin Cameron concluded his talk at the first morning session of this conference with an invitation to sex workers in the audience to take over the stage. Dr. Sunil Sunhas Solomon concluded his with a pledge to carry on the […]

AIDS 2016: Data tells “good, bad, and ugly news” of HIV death rates in east and southern Africa

By on .

Antiretroviral therapy impact is huge, but gender disparities drive differences in death rates DURBAN, South Africa –  Globally adult life expectancy gained from 10-14 years over a decade following access to HIV treatment, the greatest life expectancy gains recorded in modern history, according to researchers from the London School of Hygiene and Tropical Medicine. Greater life expectancy gains were seen […]

AIDS 2016: Medicines? Check! People to deliver them? Not so much . . .

By on .

DURBAN, South Africa – Dr. Carlos del Rio, chairman of the HIV Medicine Association, chairman of the Department of Global Health at the Rollins School of Public Health, has a pair of maps he shows medical students entering the field of infectious diseases. One shows the countries of the world sized according to the numbers of adults living with […]

AIDS 2016: Victimized, vilified by law and media, a nurse faces an uncertain future

By on .

Journalists apologize to Rosemary Namubiru, but  the damages they dealt her career, reputation, and morale persist DURBAN, South Africa – Rosemary Namubiru is a nurse, a job too few want or have trained for in Uganda, home to a still-escalating HIV epidemic, and to inequities that put preventive health care out of reach for many. It is a […]

AIDS 2016: A preconference event highlights rights, demands, and continued neglect of gay and bisexual men in global HIV response

By on .

Incidence, prevalence, laws and policies show: “We in fact are being left behind” DURBAN, South Africa – What if, as global HIV program leaders pursue unprecedented goals to close testing and treatment gaps, international donors cut their contributions to efforts in the hardest hit countries, leaving governments of those countries to pick up the slack? And what […]

AIDS 2016: TB preconference highlights response stymied by neglect of patient needs and research funding deficits

By on .

DURBAN, South Africa – Calling for change in approaches to tuberculosis to address poverty, malnutrition and human rights, International Union Against Tuberculosis and Lung Disease leader Jose Luis Castro, at a pre-conference event here Saturday, urged TB responders globally to embrace patient-centered approaches and language. That includes ending the use of nomenclature such as “TB suspect” and TB defaulters,” which […]

AIDS 2016: TB vaccine development in the 21st century takes new approaches

By on .

DURBAN, South Africa – “Can we control tuberculosis without a vaccine?” asked Willem Hanekom, of the Bill &Melinda Gates Foundation,  Saturday, and answered his own question: “No.” But if the goal continues to be imperative, the approach is changing, he told an audience at the TB 2016. On Saturday Hanekom led his audience through a description of […]